Busey Bank Boosts Stake in IQVIA Holdings Inc. (NYSE:IQV)

Busey Bank boosted its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV) by 10.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,318 shares of the medical research company’s stock after acquiring an additional 223 shares during the period. Busey Bank’s holdings in IQVIA were worth $549,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Canada Pension Plan Investment Board grew its position in shares of IQVIA by 6.6% in the second quarter. Canada Pension Plan Investment Board now owns 3,403,488 shares of the medical research company’s stock valued at $719,634,000 after purchasing an additional 211,653 shares in the last quarter. Lazard Asset Management LLC boosted its stake in IQVIA by 0.9% during the first quarter. Lazard Asset Management LLC now owns 3,263,944 shares of the medical research company’s stock worth $825,416,000 after buying an additional 30,014 shares during the last quarter. Farallon Capital Management LLC grew its holdings in IQVIA by 3.1% in the 2nd quarter. Farallon Capital Management LLC now owns 2,923,032 shares of the medical research company’s stock valued at $618,046,000 after buying an additional 86,870 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in shares of IQVIA by 3.8% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,510,685 shares of the medical research company’s stock worth $634,927,000 after acquiring an additional 92,293 shares during the period. Finally, Capital Research Global Investors boosted its position in shares of IQVIA by 7.2% during the 1st quarter. Capital Research Global Investors now owns 2,138,802 shares of the medical research company’s stock valued at $540,882,000 after acquiring an additional 143,533 shares during the last quarter. Institutional investors and hedge funds own 89.62% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Robert W. Baird lifted their target price on shares of IQVIA from $251.00 to $256.00 and gave the stock a “neutral” rating in a research note on Friday, September 20th. Jefferies Financial Group cut IQVIA from a “buy” rating to a “hold” rating and decreased their price objective for the company from $266.00 to $242.00 in a report on Wednesday, July 24th. Barclays lowered their price objective on IQVIA from $275.00 to $260.00 and set an “overweight” rating for the company in a research report on Tuesday, October 15th. Royal Bank of Canada began coverage on IQVIA in a research report on Wednesday, September 4th. They issued an “outperform” rating and a $275.00 price objective for the company. Finally, JPMorgan Chase & Co. lowered their price objective on IQVIA from $288.00 to $279.00 and set an “overweight” rating for the company in a research report on Wednesday. Five research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $267.27.

IQVIA Trading Up 1.4 %

IQV opened at $214.63 on Friday. IQVIA Holdings Inc. has a 52 week low of $167.42 and a 52 week high of $261.73. The business has a fifty day simple moving average of $238.13 and a 200-day simple moving average of $230.78. The firm has a market cap of $39.11 billion, a P/E ratio of 29.32, a P/E/G ratio of 2.22 and a beta of 1.49. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 1.80.

Insider Transactions at IQVIA

In other news, insider Eric Sherbet sold 1,300 shares of the stock in a transaction on Tuesday, August 27th. The stock was sold at an average price of $246.33, for a total value of $320,229.00. Following the sale, the insider now directly owns 19,536 shares in the company, valued at approximately $4,812,302.88. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.60% of the company’s stock.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.